Oncology Impact Fund 2, L.P. — Form D

Oncology Impact Fund 2, L.P. of CAMBRIDGE, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-11-22. $326.8M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2021-11-22
• Form: D
• Accession: 0001817314-21-000001
• Industry: Pooled Investment Fund
• Exemptions: 06b, 3C, 3C.7
• Amount sold: $326.8M
• Investors: 31
• Date of first sale: 2020-08-04
• Security types: fund interests
• Revenue range: Decline to Disclose
• SEC file number: 021-422030

Issuer

• Name: Oncology Impact Fund 2, L.P.
• CIK: 0001817314
• Entity type: Other
• Jurisdiction: CAYMAN ISLANDS
• Incorporated: 2020
• Address: 450 KENDALL STREET, CAMBRIDGE, MA, 02142
• Phone: 617-425-9200

Officers, directors & promoters (2)

More

• CIK 1817314 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search